To date, no robust environmental assessments have been conducted to compare alternative seafood to its conventional counterparts. An open-access, quantitative analysis of the relative environmental impacts of alternative seafood will help garner support for the industry from policymakers, nonprofit organizations, consumers, investors, foodservice outlets, and retailers.
A variety of plant-based scaffolds present the opportunity to combine the natural nutritional and structural benefits of plants with the taste and high protein of cultivated meat. Bacterial nanocellulose from coconut water is a particularly promising scaffold material with its FDA approval status and beneficial nutritional and cell adhesion properties.
Affordable animal-free omega-3 ingredients for alternative seafood and other alternative protein applications
In order to appeal to health-conscious consumers, alternative seafood products should contain similar omega-3 fatty acids, especially DHA and EPA, content to conventional seafood. Animal-free omega-3 ingredients can be expensive and supply can be inconsistent. Scaling up animal-free omega-3 production is critical to the success of the global alternative seafood market, which is seeing increased attention and promising growth. Adding omega-3 to other alternative protein products could also provide a great point of differentiation while improving health appeal.
Preventing oxidation of omega-3 fatty acids before and after addition to alternative seafood products
Deeper fundamental knowledge of the causes and prevention of oxidation of omega-3 fatty acids before, during, and after addition to alternative seafood products is needed to improve their nutritional and organoleptic properties. While several approaches to prevent oxidation of unsaturated lipids in conventional seafood products have been developed, antioxidation methods must be tailored to the formulations and processing of alternative seafood products, or perhaps new methods must be developed altogether.
- Bioprocess design
- Crop development
- End product formulation & manufacturing
- End Products
- Host strain development
- Ingredient optimization
- Raw Materials, Ingredients, & Inputs
- Target molecule selection
Investors specializing in alternative proteins should be leveraged to educate the broader investment community through coalitions, syndicated deals, and co-investments with industry-agnostic investors, and spearhead efforts to facilitate later-stage funding like debt and inventory financing.
Guaranteed offtake agreements, where buyers commit to purchase a volume of product, can help secure loans for infrastructure and other high-cost projects.
It can be challenging and time-intensive for startups and researchers to find funders that are interested in their technology area, technological maturity level, fundraising stage, location, type of funding sought, and other factors. Lists of investors, lenders, and grant-making institutions with specific information on interest areas and point of contact can significantly reduce friction in fundraising. Likewise, it can be difficult for funders to find out about these opportunities, so centralized listings of all companies and researchers actively seeking funding can facilitate deal flow.
The success of early-days products has demonstrated strong consumer interest, but investment is needed to enable alternative protein supply chain companies to build out the infrastructure needed to capitalize on this opportunity. In particular, there is a need for debt-based financing that can be structured to support large infrastructure projects.
Infrastructure leasing for production and processing facilities as well as capital equipment would enable alternative protein companies to rapidly expand capacity without large upfront capital investments. Having leasing funds and leasing companies with an alternative protein focus could entice corporate players who otherwise would not have considered alternative proteins to enter the space. They could also spare many smaller alternative protein startups from undertaking relatively expensive, equity-backed capital raises early in their expansion.
Events targeted at promoting opportunities in alternative protein investment via specialized funds could facilitate and diversify investment.